Product Images Terazosin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Terazosin Hydrochloride NDC 51407-733 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

51407-732-10.jpg - 51407 732 10

51407-732-10.jpg - 51407 732 10

This is a description of a medication named ENS with NDC (National Drug Code) 51407-732-10, marketed by GSMS, Incorporated in Camarillo, CA, USA. It is a capsule containing Terazosin hydrochloride, USP, which is equivalent to 1 mg terazosin. The medication is for prescription-only use and the patient information should be printed from https://gsms.us/. It is recommended to be stored in a tight light-resistant container between 20-25°C and away from light and moisture. There is a warning to keep it out of reach of children, and the dosage information is included in the accompanying Prescribing Information.*

51407-733-10.jpg - 51407 733 10

51407-733-10.jpg - 51407 733 10

This is a description of a medication called Terazosin, which comes in capsule form containing 2mg of Terazosin hydrochloride, USP. The dosage information is not available but can be found on the accompanying prescribing information. The medication should be stored at controlled room temperature, protected from light and moisture, and should be dispensed in a tightly sealed and light-resistant container. The information suggests dispensing patient information to each patient and keeping the medication out of the reach of children. The product has been marketed by GSMS, Incorporated based in Camarillo, CA, USA.*

51407-734-10.jpg - 51407 734 10

51407-734-10.jpg - 51407 734 10

Terazosin Capsules, USP with NDC 51407-734-10 are a prescription medication used to treat hypertension and benign prostatic hyperplasia. The medication contains terazosin hydrochloride, USP equivalent to 5 mg terazosin per capsule. The recommended dosage is indicated in the Prescribing Information. The medication must be stored at a temperature of 20° - 25°C (68° - 77°F) in a tightly sealed container, protected from light and moisture, and kept out of the reach of children. The manufacturer, GSMS, Incorporated, recommends that each patient should receive the Patient Information sheet, which can be printed from their website at https://gsms.us/.*

51407-735-10.jpg - 51407 735 10

51407-735-10.jpg - 51407 735 10

Terazosin Capsules, USP is a medication used to treat hypertension and benign prostatic hyperplasia (BPH). Each capsule contains 10 mg of terazosin hydrochloride, and it is only available with a prescription. The medication should be stored at room temperature and protected from light and moisture. Pharmacies should dispense the patient information leaflet with each prescription. The leaflet can be printed from the GSMS® website.*

terazosinhydrochloridechemicalstructure - chemicalstructure

terazosinhydrochloridechemicalstructure - chemicalstructure

figure1 - figure1

figure1 - figure1

figure2 - figure2

figure2 - figure2

figure3 - figure3

figure3 - figure3

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.